•  
  •  
  •  
  •  

2025-12-20 01:22:25

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • South Indian Bank Introduces RuPay SIB Paytag
  • Nifty Bank reclaims 59,000 but lacks follow-through strength
  • Nifty Ends Four-Day Losing Streak on Strong Global Cues
  • HDFC SKY Expands MTF Universe with Addition of HDFC Gold ETF
  • Nifty breaks losing streak, but continues to trade in broader consolidation range

Keywords Selected:  INE495B01038

Stock Report

  • Suven Life Sciences achieved 100% Patient Enrolment Milestone in Phase-2b Clinical Trial of Ropanicant for Major Depressive Disorder
  • Suven Life Sciences announces First Patient Randomized in Phase-2b Clinical Trial of Ropanicant
  • Suven Life Sciences to Present Positive Results from Phase-2a Proof-of-Concept Study of Ropanicant
  • Suven Life Sciences Announces Positive Topline Results from Phase-2a Proof-of-Concept Signal Detection Open Label Study of Ropanicant
  • Suven Life Sciences to present Phase-2 Positive Results on Samelisant at American Academy of Neurology2024 Annual Meeting, Denver, USA
  • Suven Life Sciences completed enrollment of patients to the phase-2, PoC clinical study of samelisant (SUVN-G3031) for the treatment of narcolepsy with or without cataplexy in USA and Canada
  • Suven Life Sciences announces Randomization of First Patient in Phase-3 Global Clinical Trial of Masupirdine
  • Suven Life Sciences Ltd approves rights issue of Rs. 400 crores
  • Suven Life Sciences Ltd Board to consider Right Issue of equity shares
  • Suven Life Sciences Limited allots 1,81,00,000 shares

Latest Post

  • South Indian Bank Introduces RuPay SIB Paytag
  • Nifty Bank reclaims 59,000 but lacks follow-through strength
  • Nifty Ends Four-Day Losing Streak on Strong Global Cues
  • HDFC SKY Expands MTF Universe with Addition of HDFC Gold ETF
  • Nifty breaks losing streak, but continues to trade in broader consolidation range


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024